Frontiers in Cardiovascular Medicine

APRIL 16, 2025

This study aimed to assess the prevalence and associated factors of left ventricular hypertrophy among adult patients with hypertension attending treatment at two public hospitals in Harar, Eastern Ethiopia from 20 December 2021 to 20 December 2023.MethodA 36.3%), with mild LVH being the most common type (51%).

Hypertension 52

Hypertension Blood Pressure Risk Factors Hospital 52

Cardiometabolic Health Congress

NOVEMBER 16, 2023

2-5, 2023, to gain perspective on the latest advances in the management of glomerular disease. Kidney Week 2023 not only served as a platform for the latest news and updates in the field but also marked the final meeting of the year for practitioners in the specialty of nephrology.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

CardiacWire

NOVEMBER 8, 2024

LimFlow gained FDA approval in September 2023, and was soon acquired by Inari Medical for up to $415M. The LimFlow system consists of several products designed to optimize blood flow in critically ischemic feet by facilitating revascularization. The post LimFlow Limits Limb-Threatening Ischemia appeared first on Cardiac Wire.

Ischemia 64

Ischemia Research Diabetes Outcomes 64

Society of Thoracic Surgeons - Critical Care

NOVEMBER 28, 2023

Video How Sweet It Isn't: Perioperative CABG Diabetes Management dkaczmarek Tue, 11/28/2023 - 11:48 Perioperative management of diabetes in CABG patients is an evolving topic.

Diabetes 52

Diabetes Cardiothoracic Critical Care 52

Cardiometabolic Health Congress

OCTOBER 26, 2023

19, 2023, attendees of the 18 th Annual CMHC in Boston heard from experts in hepatology and endocrinology in a session titled The Intersection of MASH and Cardiometabolic Risk: Applying Advances in Diagnosis and Management To Tackle The MASH Epidemic. Eckel, MD On Thursday, Oct. As of the Oct. 78(1), pp. doi: 10.1097/hep.0000000000000412.

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

CardiacWire

JANUARY 22, 2025

To tackle this problem, researchers compared Veterans Affairs data on 2 million T2D patients (2017-2023) taking either GLP-1s , DPP4is, SGLT2is, or usual care antihyperglycemics over a 3.68 year follow-up. Starting with the good news, GLP-1s lowered risks for 42 health outcomes while increasing risks for 19 outcomes.

Obesity 59

Obesity Cardiac Arrest Dementia Outcomes 59

DAIC

JUNE 21, 2024

announced that the peer-reviewed Journal of the American College of Cardiology: Heart Failure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heart failure using commonly accepted willingness-to-pay thresholds. “Our healthcare system. “Our

Heart Failure 105

Heart Failure Preserved Ejection Fraction Diabetes Research 105

Cardiometabolic Health Congress

SEPTEMBER 29, 2023

Cardiometabolic conditions – specifically obesity, diabetes and heart disease – disproportionately affect the 60 million people in the U.S. Cardiometabolic Health Congress faculty member, Fátima Rodriguez, MD, MPH, has committed much of her clinical and research efforts to reducing health disparities in Hispanic-American communities.

Health Disparities 52

Health Disparities Obesity Heart Disease Cardiovascular Disease 52

Journal of Cardiovascular Pharmacology

NOVEMBER 16, 2023

Abstract: Worldwide, type 2 diabetes is predominant form of diabetes, and it is mainly affected by the environment. In the process of diabetes onset and intergenerational transmission, the genetic structure of the individual is not directly changed but is regulated by epigenetics. Copyright © 2023 Wolters Kluwer Health, Inc.

Atherosclerosis 40

Atherosclerosis Diabetes Cardiovascular Disease Article 40

Circulation

NOVEMBER 11, 2024

Background:Poor self-care in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) leads to increased diabetes complications and health costs. using REDCap during 2023. Circulation, Volume 150, Issue Suppl_1 , Page A4115222-A4115222, November 12, 2024. years) or T2DM (n = 84, mean age: 62.5) Older age (p =.003),

Diabetes 40

Diabetes BMI Diet Exercise 40

Dr. Paddy Barrett

DECEMBER 13, 2024

Excess visceral fat results in a higher risk of insulin resistance, which is the precursor state to diabetes. The relationship between excess weight, a high BMI and the risk of severe insulin resistance and diabetes is clear 4. Relationship of BMI and Risk Of Diabetes. You put their diabetes into remission. Losing 6.5%

Heart Disease 98

Heart Disease BMI Diabetes Cardiovascular Disease 98

Stroke Journal

FEBRUARY 1, 2024

Background and Issue:Type 2 diabetes (DM2) and cardiovascular (CV) disease pose significant risks for ischemic stroke, with a heightened impact on marginalized and under-resourced communities. A diabetic educator or advanced practice nurse was consulted for patients with stroke and elevated A1c.

Diabetes 40

Diabetes Stroke Strokes Education 40

Dr. Malcolm Kendrick

DECEMBER 10, 2023

10th December 2023 A very important study – please watch Very high low density lipoprotein levels with no impact on plaque progression I interrupt my series on what is wrong with the health service to bring you breaking news. They were all healthy with none of them having diabetes, or hypertension, meaning that they were well matched.

Plaque 144

Plaque Cholesterol Diet Diabetes 144

Stroke Journal

JANUARY 30, 2025

Our purpose was to evaluate the 10-year trends in the last known well to arrival (LKWA) time in AIS patients and assess disparities.Methods:A retrospective study of consecutive AIS patients admitted to a large integrated healthcare system was performed over a 10-year period from 2014-2023. 1.66]), and comorbidities of diabetes (1.29 [1.18-1.41]),

Medicaid 40

Medicaid Stroke Strokes Outcomes 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundHigh cardiovascular mortality has been reported in young patients with diabetes. Among 1394 patients, 482 (34.6%) had diabetes. Plaque characteristics including features of vulnerability were examined by optical coherence tomography.

Plaque 40

Plaque Diabetes Cholesterol 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence.

Diabetes 40

Diabetes Coronary Artery Disease Atrial Fibrillation Dementia 40

Cardiometabolic Health Congress

JANUARY 3, 2024

It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension. at 36 weeks.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Cardiometabolic Health Congress

JUNE 27, 2024

Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress , Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions. The Diabetes Track will feature: “Precision Medicine in Diabetes” by Jose C.

CME 59

CME Diabetes Obesity Education 59

Journal of Cardiovascular Pharmacology

NOVEMBER 6, 2023

Abstract: Aim of our systematic review and meta-analysis is to compare shortened (≤3 months) dual antiplatelet therapy (DAPT) with longer DAPT in diabetic patients undergoing percutaneous coronary interventions (PCI). Thus, S-DAPT could be considered as a safe and feasible option in diabetic patients. All rights reserved.

Diabetes 40

Diabetes Myocardial Infarction Thrombosis Stent 40

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. However, there is ongoing debate whether intensive BP lowering may paradoxically increase the risk of cardiovascular disease (CVD), especially in patients with type 2 diabetes (T2D).

Blood Pressure 40

Blood Pressure Diabetes Cardiovascular Disease Outcomes 40

The British Journal of Cardiology

MARCH 7, 2024

Held in London on 6 th October 2023, this popular meeting mixed presentations from experts in cardiology, diabetes and renal medicine with the opportunity for delegates to network, share and discuss their knowledge and expertise. Dr Mohammad Wasef and Dr Sarah Birkhoelzer report its highlights.

Diabetes 40

Diabetes Kidney Disease Stenosis Aortic 40

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

This meta-analysis aimed to assess its impact on outcomes.MethodsA search of Medline and Cochrane up to February 2023 was conducted to identify randomized controlled trials and observational studies comparing patients undergoing early CAG vs. delayed/no CAG after experiencing out-of-hospital cardiac arrest.

Cardiac Arrest 59

Cardiac Arrest Myocardial Infarction Hospital Diabetes 59

Circulation

NOVEMBER 11, 2024

Background:Clinical trials have demonstrated that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) reduce cardiovascular (CV) risk in patients (pts) with type 2 diabetes (T2D) with or at high risk for CV disease. 1.04, P=0.3). 0.98, P=0.025).Conclusions:Among

Coronary Artery Disease 40

Coronary Artery Disease Diabetes Circulation Outcomes 40

Journal of the American Heart Association

DECEMBER 1, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. 1.58] per 10‐beat increase from 60 bpm) after excluding participants who smoked; had hypertension, diabetes, or hyperlipidemia; or were overweight.ConclusionsAn RHR of ≥80 bpm is significantly associated with an increased risk of ESRD.

Risk Factors 75

Risk Factors Cardiovascular Disease Kidney Disease Diabetes 75

Journal of the American Heart Association

APRIL 3, 2025

We evaluated associations between patient characteristics and 3month RTW status, augmenting these findings with a systematic review and metaanalysis of PubMed, Embase, Scopus, and Cochrane databases from January 2000 to November 2023.

Stroke 45

Stroke Strokes Atherosclerosis Diabetes 45

Circulation: Cardiovascular Imaging

OCTOBER 26, 2023

Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e016023, November 1, 2023.

Article 40

Article Cardiovascular Imaging Hypertension Diabetes 40

CardiacWire

AUGUST 18, 2024

If these first 10 reductions were in place in 2023, it would have cut $6B in prescription costs, which actually represents a much smaller 22% net reduction due to these drugs’ pre-existing Medicare discounts and rebates.

Medicare 59

Medicare CMS Drug Costs Diabetes 59

Circulation: Cardiovascular Imaging

OCTOBER 26, 2023

Circulation: Cardiovascular Imaging, Volume 16, Issue 11 , Page e016087, November 1, 2023.

Cardiovascular Imaging 40

Cardiovascular Imaging Article Hypertension Diabetes 40

Dr. Paddy Barrett

AUGUST 30, 2024

Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heart disease. 2023 Jul;4(7):e345-e353. 2023 May;31(5):1204-1215. 2023 May 23;100(21):e2191-e2203. 2023 Feb 6;69:101764. Poor Sleep Is A Major Risk Factor For Insulin Resistance. Lancet Healthy Longev.

Heart Disease 111

Heart Disease Dementia Obesity Heart Attack 111

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24 12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

FEBRUARY 26, 2025

This study aims to investigate the relationship between sdLDLC level and PP in patients with stable coronary artery disease.MethodsWe conducted a retrospective analysis of 146 lesions in 86 patients by repeat intravascular ultrasound examinations from January 2020 to May 2023. P=0.006), especially in diabetic patients (Pearsonr=0.58,P<0.001).

Ultrasound 56

Ultrasound Plaque Cholesterol Coronary Artery Disease 56

Science Daily - Heart Disease

NOVEMBER 13, 2023

Semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes, according to new research.

Obesity 40

Obesity Cardiovascular Disease Diabetes Risk Factors 40

International Journal of Cardiovascular Sciences

MARCH 13, 2023

The International Journal of Cardiovascular Science (IJCS) is accepting articles for a special thematic issue focusing on cardiometabolic diseases, to be published in September 2023. The term cardiometabolic risk describes the chances that a person has of damaging the cardiovascular system when one or more risk factors appear together.

Pharmacology 52

Pharmacology Article Obesity Risk Factors 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. vs 72, p<0.001) compared to patients who did not have poorly controlled diabetes. or greater.

Outcomes 40

Outcomes Angioplasty Atrial Fibrillation Diabetes 40

Cardiometabolic Health Congress

JANUARY 26, 2024

Astronomically high insulin costs have led to complications and barriers to access for millions of Americans with diabetes. Patient Assistance Program (PAP) : Offers free diabetes medication to people in need who meet specific eligibility criteria. How: Go to the website or call the Lilly Diabetes Solution Center at 1-833-808-1234.

Medicare 59

Medicare Medicaid Diabetes Download 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Databases including Embase, PubMed, The Cochrane Library, Web of Science, CNKI, Wanfang Data, VIP, and SINOMED were comprehensively searched for identifying studies published from 1977 to 19 May 2023. The commonly used predictor variables include LVEF, age, Killip classification, diabetes, and various others.

Myocardial Infarction 59

Myocardial Infarction STEMI Article Diabetes 59

Stroke Journal

JANUARY 30, 2025

Ensuring a follow-up neurology appointment within two weeks is vital to managing stroke risk factors like hypertension, diabetes, and atrial fibrillation. The first period, from July 2022 through June 2023, represents the timeframe before the opening of the transition-of-care clinic.

Stroke 40

Stroke Strokes Risk Factors Hemorrhage 40